Pietro Scilipoti/eventscribe.net
Dec 29, 2024, 13:42
The Financial Burden of Localized and Metastatic Bladder Cancer
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, shared a recent article by on X:
“Bladder cancer care is very expensive these days .
Costs skyrocket from $200K+ for high-risk non—muscle-invasive bladder cancer (NMIBC) cases to $100K per treatment in advanced dz.
What’s the solution here ?
Title: The Financial Burden of Localized and Metastatic Bladder Cancer
Authors: Pietro Scilipoti, Marco Moschini, Roger Li, Seth P. Lerner, Peter C. Black, Andrea Necchi, Morgan Rouprêt, Shahrokh F. Shariat, Shilpa Gupta, Alicia K. Morgans, Sarah P. Psutka and Ashish M. Kamat
More posts featuring Laura Bukavina.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 4, 2025, 15:08
May 4, 2025, 15:06
May 4, 2025, 14:06
May 4, 2025, 13:27